Live feed
Filing
SC 13G
SC 13G0000935836-14-000642·Tobira Therapeutics, Inc.
Schedule 13G ownership disclosure
Regado Biosciences Inc
Security class unavailable · CUSIP: 75874Q107
Event date: 2014-11-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,954,621
- Percent of class
- 5.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-14-000642
- Form type
- SC 13G
- Filer
- Tobira Therapeutics, Inc.
- CIK
- CIK 1311596
- Filed
- Nov 26, 2014
- Reporting period
- Nov 17, 2014
- Description
- Schedule 13G beneficial ownership